Company news
Nexsen Limited (ASX:NXN) news
Nexsen Limited news releases on 6ix. Latest, Sep 25, 2026: Reinstatement to Quotation
Press releases & updates
Reinstatement to Quotation
September 24, 2026
Suspension from Quotation
September 23, 2026
Trading Halt
September 21, 2026
Annual Report - FY 2026
August 30, 2026
Quarterly Report - Q4 FY26
July 28, 2026
$1.5m non-dilutive ARC funding for manufacturing
June 24, 2026
Nexsen secures first hospital partner in Asia
May 12, 2026
Nexsen and Universiti Malaya launch joint facility
May 3, 2026
Quarterly Report - Q3 FY26
April 27, 2026
QMS milestone achieved
April 6, 2026
HK$6 million grant awarded to advance Asia-Pacific execution
March 30, 2026
Nexsen accelerates global rollout for StrepSure
March 25, 2026
FDA feedback derisks US approval pathway for StrepSure
March 22, 2026
Half Yearly Report and Accounts
February 26, 2026
Quarterly Report - Q2 FY26
January 29, 2026
$500k govt grant expands GBS project to neonates
January 26, 2026
Investor Presentation
December 7, 2025
Nexsen Appoints Global Clinical Leader to the Board
December 2, 2025
Quarterly Report - Q1 FY26
October 31, 2025
Nexsen launches clinical trial for GBS Rapid Sensor
October 20, 2025